UK Freephone Orders
0800 387732
9am to 5pm Mon-Fri
International Orders
+44 2380 487209
Select Your Country
Serum Infliximab Quantitative lateral-flow test used with the BÜHLMANN Quantum Blue® reader for measuring trough Infliximab levels. Range 0.4-20µg/ml
Pack size: 25 tests
Product code: LF-TLIF25

This product is for Professional Use only and not for sale to the general public for home use. Please log in with a business account to purchase.

This product is not available for direct sale from this website to countries outside of the UK.

Please Enquire

Serum Infliximab Quantitative lateral-flow test used with the BÜHLMANN Quantum Blue® reader for measuring trough Infliximab levels. Range 0.4-20µg/ml

The BÜHLMANN Quantum Blue® Infliximab assay is an immunoassay for the quantitative determination of infliximab trough levels in human serum which can be used to support therapy monitoring. Generally, trough levels in serum that reach a value of 3µg/ml and above correlate well with remission, endoscopic healing of the gut mucosa and low CRP values as well as prediction of sustained response to infliximab therapy.

The test is designed for the selective measurement of infliximab by a sandwich immunoassay. Recombinant tumour necrosis factor alpha (TNFα) is conjugated to gold colloids. On the test cassette the conjugate is released from the pad onto the reastion system as the sample is applied. Infliximab present in the sample will bind to the conjugate. A highly specific monoclonal antibody is immobilised on the test membrane and will capture the conjugate/analyte complex, resulting in a colouring of the test line. The remaining free TNFα/gold conjugate will bind to the control line. The signal intensities of the test line and the control line are measured quantitatively by the BÜHLMANN Quantum Blue® reader.

Specimen Collection and Storage: Collect blood into a plain venipuncture tube without any additives, avoiding hemolysis. Let the serum clot at room temperature for between 20-60 minutes. Centrifuge at room temperature at ~2000g for 15 minutes. Decant the serum. Serum samples can be stored refrigerated at 2-8ºC for up to 3 days and at ≤ -20ºC for at least 3 months.

Test Details:

LF-TLIF25 is read using a second generation Quantum Blue® reader

Sample type: Serum

Sample volume: 10µl

Test time: 15 minutes

Assay range: 0.4-20µg/ml

Interpretative criteria:

Below 3µg/ml = low infliximab levels in serum should be used to help the decision to alter the medication, by either dose increase, shortening infusion intervals or a change of drug

Between 3-7µg/ml = trough levels within the therapeutic window can support evidence of effective drug treatment with infliximab, when patients are symptom free

Above 8µg/ml = dose de-escalation to reach the optimal therapeutic window (3-7µg/ml) has no effect on CRP values, Harvey Bradsaw, or Mayo scores on Crohn's or ulcerative colitis patients respectively

Limit of Detection: 0.15µg/ml

Hook Effect: No hook effect was observed up to 1000µg/ml infliximab

Interfering Substances:

Within-Class: No interference was detected with up to 10µg/ml adalimumab, ethanercept and golilimab and up to 1.7µg/ml of certolizumab

Serum Indices: No interference was detected with the following substances up to the stated concentrations:

Triglycerides - intralipid 1320mg/ml; equivalent to 37 mmol/l triglyceride

Conjugated Bilirubin - 342µmol/l; 29mg/dl

Unconjugated Bilirubin - 342µmol/l; 20mg/dl

Haemoglobin - 2g/l; 200mg/dl

TNFα - 2.6ng/ml

Rheumatoid factors - 497.3IU/ml

Immunsuppressive/Co-Medication: No interference was detected with azathioprine (60µmol/l), 6-mercaptopurine (37µmol/l) and methotrexate (1363µmol/l)

Lot specific controls are included within the kit
Brand
BÜHLMANN
Sterile
No
CE Certified
CE IVD
Warranty Period
Standard Terms Apply
Measuring Range
0.4-20µg/ml
Sensitivity
0.15µg/ml
Contents
25 individually sealed test cassettes, 1x10ml chase buffer,2 RFID cards (one green and one white)
Detected Chemical
serum infliximab
UNSPSC Description
Chemistry test kits or supplies
UNSPSC Code
41116104
NHS eClass Description
Chemical & Biochemical Diagnostic Products
NHS eClass Code
HHB
Pack Description
25 tests
Shipping Condition
Ambient
Storage Condition
Fridge
Pack Length (m)
0.22
Pack Width (m)
0.15
Pack Height (m)
0.12
Pack Weight (Kg)
1.0000

Write your own review

You're reviewing:

Serum Infliximab Quantitative lateral-flow test used with the BÜHLMANN Quantum Blue® reader for measuring trough Infliximab levels. Range 0.4-20µg/ml



How do you rate this product? *


 
1 1 star
2 2 star
3 3 star
4 4 star
5 5 star
Quality
Ease of Use
Value for Money

  • 2018 Quantum Blue® Brochure

    • PDF size: 2.26MB
    • Updated on: 08/10/2018

    Rapid, Reliable Results

    Open File
  • Quantum Blue® Therapeutic Drug Monitoring Assays

    • PDF size: 9.85KB
    • Updated on: 04/07/2018

    Infliximab and Adalimumab Product Flyer

    Open File
  • The new biosimilar of infliximab SB2 can be quantified by IFX-optimized therapeutic drug monitoring assays

    • PDF size: 31.48KB
    • Updated on: 03/08/2018

    Alfonso et al. ECCO

    Open File
  • Quantum Blue® Infliximab POC User Performance Evaluation

    • PDF size: 12.36KB
    • Updated on: 03/08/2018

    Fellay et al. ECCO 2018 Poster No. 767

    Open File
  • Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

    • PDF size: 10.93KB
    • Updated on: 03/08/2018

    Alfonso et al. Aug 17

    Open File
  • The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximab

    • PDF size: 10.34KB
    • Updated on: 03/08/2018

    Alfonso et al. Poster at ECCO 2018

    Open File
  • Clinical performance of an infliximab rapid quantification assay

    • PDF size: 11.02KB
    • Updated on: 03/08/2018

    Magro et al. Aug 17

    Open File
  • Patient-near Infliximab trough-level testing by a novel quantitative rapid test: The Quantum Blue Infliximab test

    • PDF size: 11.01KB
    • Updated on: 03/08/2018

    Lindsjø et al. Poster - UEG Week October 2016

    Open File
  • Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays

    • PDF size: 9.51KB
    • Updated on: 03/08/2018

    Afonso J et al. Aliment Pharmacol Ther. 2016 Oct;44(7):684-92

    Open File
  • Performance of the BÜHLMANN Quantum Blue® Infliximab point-of-care assay dedicated for therapeutic drug monitoring of serum infliximab trough levels

    • PDF size: 12.37KB
    • Updated on: 03/08/2018

    ECCO, March 16-19, 2016, Poster No. 242

    Open File

Contact

Please contact us if you require further information about this product.




Your request will be forwarded to the relevant department to assist with your enquiry.
By clicking 'Send Enquiry' you are authorising Alpha Laboratories to process your information and use it to contact you so that we may respond to your request, as well as to communicate with you regarding our products and services.

Submitting your details indicates that you agree to our Privacy Policy.

* Required Fields